Workflow
Guanfu Holdings(002102)
icon
Search documents
冠福股份(002102) - 2015年7月6日投资者关系活动记录表
2022-12-07 08:31
投资者关系之二 证券代码:002102 证券简称:冠福股份 福建冠福现代家用股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |----------------|--------------------------------------------|-------------------------------------|--------------------------------------------------| | | | | | | | 编号: | | | | | ■ | 特定对象调研 □分析师会议 | | | | □ | 媒体采访 □业绩说明会 | | | 投资者关系活动 | □ | 新闻发布会 □路演活动 | | | 类别 | □ 现场参观 | | | | | | □其他 (请文字说明其他活动内容) | | | | | 兴业全球基金管理有限公司 张弘 | | | | 中信证券股份有限公司 田加强 | | | | 参与单位名称及 | 敦和资产管理有限公司 陈颖 | | | | 人员姓名 | | 中国人寿养老保险股份有限公司 张树声 | | | | | ...
冠福股份(002102) - 2016年9月9日投资者关系活动记录表
2022-12-06 09:54
投资者关系之二 证券代码:002102 证券简称:冠福股份 冠福控股股份有限公司 投资者关系活动记录表 编号: | --- | --- | --- | |---------------------|------------|-------------------------------------------| | | | | | | | | | | ■ | 特定对象调研 □分析师会议 | | | □ | 媒体采访 □业绩说明会 | | 投资者关系活动 类别 | □ | 新闻发布会 □路演活动 | | | ■ 现场参观 | | | | | □其他 (请文字说明其他活动内容) | | 参与单位名称及 | 1 | 、中泰证券股份有限公司 宁浮洁、赵磊 | | 人员姓名 | 2 | 、汇添富基金管理有限公司 林小伟 | | | 3 | 、富国基金管理有限公司 宋哲建、姜恩铸 | | | | 4、北京市星石投资管理有限公司 郭希淳 | | | 5 | 、信达金融租赁有限公司 王卫平 | | | 6 | 、东方证券股份有限公司 吴钊华 | | | 7 | 、上海国富投资管理有限公司 陈佳晨 | | | 8 | 、信诚基 ...
冠福股份(002102) - 2016年9月1日投资者关系活动记录表
2022-12-06 01:28
投资者关系之二 证券代码:002102 证券简称:冠福股份 冠福控股股份有限公司 投资者关系活动记录表 编号: | --- | --- | --- | |---------------------|-------------------------------------------|---------------------------------------------| | | | | | | | | | | ■ 特定对象调研 □分析师会议 | | | | □ 媒体采访 □业绩说明会 | | | 投资者关系活动 类别 | □ 新闻发布会 □路演活动 | | | | □ 现场参观 | | | | □其他 (请文字说明其他活动内容) | | | 参与单位名称及 | 1 、国海证券股份有限公司 梁欢 | | | 人员姓名 | 2 | 、中泰证券股份有限公司 宁浮洁、赵磊、周思捷 | | | 3、金库创业投资管理有限公司 黄琳佳 | | | | 4、国金证券股份有限公司 蒋明远、廖德高 | | | | 5 、交通银行上海闵行支行工商企业部 成 | 静 | | | 6 、交通银行上海闵行支行公司业务部 周淼鑫 | ...
冠福股份(002102) - 2018年5月15日投资者关系活动记录表
2022-12-03 09:50
投资者关系之二 证券代码:002102 证券简称:冠福股份 冠福控股股份有限公司 投资者关系活动记录表 编号:2018-001 | --- | --- | --- | |---------------------|---------------------------------------|----------------------| | | ■ 特定对象调研 □分析师会议 | | | | □ 媒体采访 □业绩说明会 | | | 投资者关系 活动类别 | □ 新闻发布会 | □路演活动 | | | ■ 现场参观 | | | | □其他 (请文字说明其他活动内容) | | | | 1 、深圳市前海瑞松投资有限公司 | 关林戈、张向阳、王涵 | | | 2 、君诚资本管理有限公司 牛奔、骆莹莹 | | | | 3 、第一创业证券股份有限公司 | 刘红星 | | 参与单位名称及 | 4 、博时基金管理有限公司 陈西铭 | | | 人员姓名 | 5 、华创证券有限责任公司 | 冯自立 | | | 6 、长城基金管理有限公司 唐然 | | | | 7、德邦证券股份有限公司 张曙 | | | | 8 、王诗平、刘东莹 ...
冠福股份(002102) - 2022 Q3 - 季度财报
2022-10-26 16:00
Financial Performance - The company's revenue for Q3 2022 was ¥3,423,972,447.04, representing a 6.19% increase year-over-year, while year-to-date revenue decreased by 7.44% to ¥9,054,488,549.58[7] - Net profit attributable to shareholders for Q3 2022 was ¥68,315,989.72, a decrease of 63.19% compared to the same period last year, while year-to-date net profit increased by 146.78% to ¥663,214,886.77[7] - Basic earnings per share for Q3 2022 was ¥0.0259, down 63.26% year-over-year, while year-to-date earnings per share increased by 146.86% to ¥0.2518[7] - The company reported a total revenue of 1,000,000.00 in the third quarter of 2022[32] - Net profit for the current period reached 675,759,212.03, a significant increase from 291,595,385.56 in the previous period, representing a growth of approximately 131.5%[81] - Operating profit increased to 727,819,219.78 from 396,892,229.30, marking a rise of about 83.4%[81] - Total revenue from operating activities decreased to 10,181,979,746.86 from 11,059,608,220.17, reflecting a decline of about 7.9%[86] Assets and Liabilities - Total assets at the end of Q3 2022 were ¥9,393,984,278.16, a slight increase of 0.36% from the end of the previous year[7] - Total liabilities decreased to approximately ¥5.17 billion from ¥5.81 billion, indicating a reduction of about 10.7%[74] - The company's total equity attributable to shareholders increased to approximately ¥4.08 billion from ¥3.42 billion, reflecting a growth of about 19.3%[77] - The company's cash and cash equivalents increased significantly to ¥693.65 million from ¥304.29 million at the beginning of the year, representing a growth of approximately 128.5%[68] Cash Flow - Cash flow from operating activities for the year-to-date period decreased by 675.19% to -¥233,137,617.83, primarily due to an increase in bank acceptance bill deposits[18] - Cash flow from operating activities showed a net outflow of -233,137,617.83, compared to a net inflow of 40,532,119.92 in the previous period[89] - Investment activities generated a net cash outflow of -164,411,918.75, an improvement from -264,087,151.58 in the previous period[92] - Financing activities produced a net cash inflow of 610,102,220.16, up from 226,038,843.97, indicating a growth of approximately 169.5%[92] Shareholder Information - The total number of common shareholders at the end of the reporting period is 40,265[21] - The largest shareholder, Jingzhou Chengfa Capital Operation Co., Ltd., holds 10.11% of shares, totaling 266,172,498 shares[21] - Chen Liequan, a significant shareholder, holds 8.81% of shares, amounting to 232,163,822 shares, with 230,372,866 shares under lock-up[21] - The company has a total of 10 major shareholders, with the top 10 holding significant stakes in the company[21] Legal and Compliance Issues - The company is currently under risk warning due to previous violations by its former controlling shareholder, affecting stock trading limits[25] - The company is actively taking measures to resolve the impact of the former controlling shareholder's violations and is committed to timely information disclosure[25] - The company has faced legal actions leading to the freezing of bank accounts and assets due to the former controlling shareholder's actions[29] - The company has been consistently updating the public on the progress of measures taken to lift the risk warning since 2018[26] - The company will continue to protect its legal rights and interests in response to the ongoing legal issues[29] - The company has recognized bad debt losses and contingent liabilities related to the original controlling shareholder's violations[41] - The company has initiated legal proceedings to recover compensation from the original controlling shareholder and related parties[37] Legal Disputes and Settlements - The company has received 328 lawsuits related to the defaulted bonds, with 215 cases already adjudicated[36] - The company has reached settlements with 539 creditors, totaling RMB 378 million, which accounts for 90.33% of the overdue private placement bond amount[36] - The company has resolved multiple legal disputes, including amounts of 6 million, 24 million, and 19 million, contributing to a more stable financial environment[8][9][11] - The company has a history of legal settlements, with amounts frequently reaching 10,000,000.00 CNY or more, indicating a pattern of litigation[69][72][73] - The company has faced legal challenges that have resulted in significant financial settlements, impacting its overall financial health[71][78] Operational Focus and Strategy - The company is focusing on expanding its market reach through strategic partnerships and potential acquisitions[46][47][48][49][50] - The company is exploring new product development opportunities, although specific details were not disclosed[32][46] - The company continues to maintain its operational structure despite ongoing legal challenges[32] - The company is actively managing its legal disputes to mitigate financial impacts on its operations[56][57][58][59]
冠福股份(002102) - 2022 Q2 - 季度财报
2022-08-22 16:00
Financial Performance - The company's operating revenue for the reporting period was ¥5,630,516,102.54, a decrease of 14.14% compared to the same period last year[51]. - Net profit attributable to shareholders was ¥594,898,897.05, representing a significant increase of 615.22% year-on-year[51]. - The net profit after deducting non-recurring gains and losses was ¥164,571,372.83, up 36.48% from the previous year[51]. - The company's total assets at the end of the reporting period were ¥9,649,940,040.96, an increase of 3.10% compared to the end of the previous year[51]. - The net assets attributable to shareholders increased by 17.42% to ¥4,014,291,705.72[51]. - The company reported a negative net cash flow from operating activities of ¥144,718,623.94, a decline of 266.76% year-on-year[51]. - Basic earnings per share rose to ¥0.2259, reflecting an increase of 614.87% compared to the same period last year[51]. - The weighted average return on equity was 16.01%, up from 2.48% in the previous year, indicating improved profitability[51]. - Total revenue for the period was ¥5,630,516,102.54, a decrease of 14.14% compared to ¥6,557,673,912.18 in the previous period[89]. - Trade business revenue was ¥5,087,000,873.30, accounting for 90.35% of total revenue, down 15.40% from ¥6,013,064,328.55[89]. - Domestic revenue was ¥5,386,625,264.32, representing 95.67% of total revenue, a decline of 15.60% from ¥6,382,212,262.84[89]. - The gross profit margin for the trade business was 0.52%, down 15.40% year-on-year[89]. - Investment income surged by 846.91%, primarily due to increased debt restructuring gains[93]. - The company's cash and cash equivalents increased by 42.45%, largely due to an increase in bank acceptance bill guarantees[92]. - Short-term borrowings rose by 48.61%, reflecting increased external financing[92]. Asset Management - The company reported a total asset value of 96.56 billion CNY as of June 30, 2022, with goodwill accounting for 17.28 billion CNY, representing 17.91% of total assets[14]. - The company plans to optimize its asset structure by selling non-core assets, including gold mining assets, to improve asset operation and capital efficiency[11]. - The company acknowledges the risk of goodwill impairment due to potential deterioration in the operating conditions of acquired entities[14]. - The company has a goodwill balance of CNY 1.728 billion, accounting for 17.91% of total assets, which poses a risk of impairment[130]. - The company has incurred a total of 987,890,194.73 CNY due to non-operating fund occupation as of the end of the reporting period[166]. - The company’s total assets provided guarantees for debts, with a total of 172.82 million yuan in non-operating fund occupation by controlling shareholders and related parties[163]. Legal and Compliance Issues - The company has received administrative penalties from the China Securities Regulatory Commission, leading to increased litigation and compensation risks from investors[19]. - The company is actively responding to legal challenges and has initiated legal procedures to recover debts on behalf of its original controlling shareholder[18]. - The company faces operational risks in its mining segment due to a lack of technical talent and management experience, which may lead to discrepancies between estimated and actual resource extraction[11]. - The company has been involved in legal disputes related to the original controlling shareholder's violations, amounting to CNY 2.37 billion[131]. - The company is facing ongoing challenges with the original controlling shareholders regarding the resolution of non-operating fund occupation[168]. - The board has criticized the former chairman and general manager for their roles in the violations and has mandated corrective actions[166]. - A professional legal team has been established to protect the company's and shareholders' rights in response to the former controlling shareholder's misconduct[191]. - The company is actively pursuing measures to mitigate risks associated with the former controlling shareholder's violations, including asset restructuring and debt resolution strategies[190]. Operational Efficiency and Risk Management - The company emphasizes the importance of maintaining operational efficiency and risk control as it expands its business and diversifies its operations[12]. - The company has established a comprehensive human resource management and talent incentive mechanism, but still faces risks related to the potential loss of core technical personnel[13]. - The company has implemented significant cost-saving measures at its Shanghai property to improve profitability and operational efficiency[67]. - The company is focusing on enhancing its B2B platform, "塑米城 3.0," which integrates various services to improve customer experience and operational efficiency[80]. - The company has implemented governance improvements to enhance operational compliance and oversight, including strengthening the roles of independent directors and the supervisory board[193]. Environmental Compliance - The company has implemented a wastewater treatment facility with a processing capacity of 200 tons per day, ensuring compliance with discharge standards[146]. - The company has engaged in five pollution discharge rights trading activities, obtaining discharge rights for all constructed projects[150]. - The company has installed online monitoring systems for wastewater discharge and hazardous waste incineration to ensure compliance with environmental regulations[152]. - The company has adopted clean energy, specifically natural gas, for its boiler operations to reduce emissions[146]. - The company has conducted emergency drills for environmental incidents annually to ensure preparedness[151]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[153]. Shareholder and Governance Matters - The company held three shareholder meetings during the reporting period, with participation rates of 23.43%, 26.40%, and 4.33% respectively[136]. - The company has undergone a board member election on July 8, 2022, with several new appointments including the chairman and vice chairman[140]. - The company will not distribute cash dividends or issue bonus shares for the current fiscal year[7]. - The company has not implemented any employee stock ownership plans or other incentive measures during the reporting period[141]. - The company has a commitment to timely information disclosure as events progress[105]. Charitable Contributions - The company donated a total of 1.1 million yuan to various charitable organizations during the reporting period, including 100,000 yuan to the Dehua County Charity Federation[155].
冠福股份(002102) - 2022 Q1 - 季度财报
2022-04-25 16:00
Financial Performance - Revenue for Q1 2022 was CNY 2,812,483,534.53, a decrease of 5.89% compared to CNY 2,988,443,936.65 in the same period last year[4] - Net profit attributable to shareholders increased by 116.82% to CNY 115,251,288.22 from CNY 53,154,680.28 year-on-year[4] - Basic earnings per share rose by 116.83% to CNY 0.0438 from CNY 0.0202 in the same period last year[4] - Net cash flow from operating activities improved by 135.03%, reaching CNY 30,132,613.90 compared to a negative CNY 86,028,496.68 in the previous year[4] - Total operating revenue for the current period is ¥2,812,483,534.53, a decrease of 5.9% from ¥2,988,443,936.65 in the previous period[55] - Net profit for the current period is ¥123,685,307.11, compared to ¥59,492,554.08 in the previous period, indicating a significant increase of 108.3%[59] - The net profit attributable to the parent company is ¥115,251,288.22, up from ¥53,154,680.28, marking a growth of 116.7%[59] - The company reported an investment income of ¥34,248,920.95, significantly higher than ¥17,158,521.12 from the previous period, indicating improved investment performance[57] Assets and Liabilities - Total assets at the end of the reporting period were CNY 9,537,808,792.48, an increase of 1.90% from CNY 9,359,889,356.84 at the end of the previous year[5] - Total liabilities increased from 4,497,082,502.56 CNY to 4,553,593,812.50 CNY, reflecting a rise of about 1.3%[52] - Total current assets increased from 3,629,440,243.74 CNY to 3,835,228,309.27 CNY, marking an increase of about 5.7%[50] - The company's total assets rose from 9,359,889,356.84 CNY to 9,537,808,792.48 CNY, indicating a growth of approximately 1.9%[52] - Total equity attributable to shareholders of the parent company is ¥3,534,542,631.98, up from ¥3,418,813,143.63, reflecting a growth of 3.4%[54] Shareholder Information - Total number of common shareholders at the end of the reporting period is 40,500[12] - The largest shareholder, Chen Liequan, holds 11.66% of shares, totaling 307,163,822 shares[12] - The second-largest shareholder, Shantou Jinchuangying Investment Consulting, holds 8.79% of shares, totaling 231,478,254 shares[12] - The third-largest shareholder, Lin Fuchun, holds 5.13% of shares, totaling 135,027,006 shares[12] Legal and Compliance Issues - The company has been under risk warning since October 16, 2018, due to violations by the former controlling shareholder[15] - The stock trading limit is set at 5% due to the risk warning[15] - The company is actively taking measures to resolve the impact of the former controlling shareholder's violations[18] - The company has faced legal actions leading to the freezing of bank accounts and assets due to the former controlling shareholder's actions[18] - The company will continue to disclose information according to legal and regulatory requirements as events progress[18] - The total amount involved in litigation cases is approximately 2.36 billion RMB, excluding interest and other penalties[39] - The company has engaged in multiple lawsuits, with some cases already settled or mediated[41] - The company has a significant ongoing rental dispute with Xiamen Haixi Mingzhu Investment Management Co., which has led to legal actions[42] - The company has engaged professional lawyers to respond to the lawsuit and will closely monitor the case's progress[44] Operational Strategies and Future Outlook - The company provided a positive outlook for the upcoming quarters, projecting a revenue growth of 15% year-over-year based on current market conditions[30] - New product development is underway, with an investment of 25 million allocated for research and innovation in the next fiscal year[15] - The company is expanding its market presence, targeting an additional 10% market share in the Asia-Pacific region by the end of 2019[30] - A strategic acquisition was announced, with a deal valued at 59 million aimed at enhancing the company's product offerings and market reach[14] - The company plans to launch a new technology platform in Q3 2018, which is expected to drive user growth by 20%[30] - Operational efficiency improvements are projected to reduce costs by 5 million annually, enhancing overall profitability[24] - The company is exploring partnerships with local firms to strengthen its supply chain, aiming for a 10% reduction in logistics costs[30] - A new marketing strategy is set to roll out, focusing on digital channels, with a budget increase of 15% to boost brand visibility[30] Cash Flow and Financial Management - Cash flow from investing activities showed a net outflow of ¥123,450,051.00, worsening from a net outflow of ¥35,940,666.18 in the previous period[63] - Cash inflow from financing activities decreased to ¥203,844,695.80 from ¥275,524,777.98, a decline of approximately 26%[63] - The net cash flow from financing activities turned negative at -¥2,732,011.49, contrasting with a positive net flow of ¥113,384,572.03 in the previous period[63] - The ending balance of cash and cash equivalents dropped to ¥26,579,560.57, down from ¥557,331,281.73, indicating a significant decrease of about 95.2%[63] - Payments to employees increased to ¥34,587,543.91 from ¥26,735,492.54, reflecting a rise of approximately 29.2%[61] - Payments for other operating activities surged to ¥697,315,695.14, compared to ¥138,914,265.34 in the previous period, marking an increase of about 403%[61]
冠福股份(002102) - 2021 Q4 - 年度财报
2022-04-18 16:00
Financial Performance - The company reported a significant increase in revenue, achieving a total of 236,565.62 million RMB, marking a year-on-year growth of 15%[11]. - The company's operating revenue for 2021 was ¥13,532,557,657.25, representing a 5.38% increase from ¥12,841,679,568.72 in 2020[45]. - Total revenue for 2021 was ¥13,532,557,657.25, representing a year-on-year increase of 5.38% from ¥12,841,679,568.72 in 2020[93]. - The pharmaceutical and chemical sector saw significant growth, with revenue increasing by 59.60% to ¥861,026,723.37, up from ¥539,507,178.53 in 2020[93]. - Domestic revenue accounted for 97.04% of total revenue, amounting to ¥13,132,478,641.59, which is a 5.98% increase compared to the previous year[93]. - The net profit attributable to shareholders for 2021 was ¥101,086,643.60, a decrease of 19.46% compared to ¥125,503,753.72 in 2020[45]. - The basic earnings per share for 2021 was ¥0.0384, a decline of 19.50% from ¥0.0477 in 2020[45]. - The net profit attributable to shareholders in Q4 2021 was -¥167,659,165.82, indicating a significant loss compared to profits in earlier quarters[50]. - The total non-recurring gains and losses amounted to ¥64,109,419.34 in 2021, compared to ¥82,408,063.80 in 2020[55]. Investment and Development - The company plans to invest 100 million RMB in new product development and technology research in the upcoming fiscal year[11]. - The company is exploring strategic acquisitions to enhance its market position and diversify its product offerings[11]. - The company invested 120 million CNY to acquire a 40% stake in Tianke (Jingzhou) Pharmaceutical Co., enhancing its industrial chain from intermediates to active pharmaceutical ingredients[71]. - The company is actively seeking to sell its real estate assets in Qingpu District, Shanghai, to improve asset utilization and reduce financial pressure[70]. - The company aims to achieve a stable income and profit growth by expanding its product sales market and improving production efficiency through advanced manufacturing processes[111]. - The company plans to adjust product structure and enhance core product competitiveness through ongoing R&D projects, including RD50, RD52, and RD53[108]. Risk Management - The company has identified key risks, including operational management challenges due to rapid expansion and potential talent retention issues[11]. - The company has received a qualified audit opinion from its accounting firm, highlighting certain operational risks that need to be addressed[11]. - The company is actively managing legal risks related to past disclosures and is working with legal advisors to mitigate potential impacts[11]. - The company is facing significant liabilities due to guarantees provided for a private placement bond of up to 600 million yuan, resulting in a non-operating fund occupation balance of 1,728.21 million yuan by the original controlling shareholder[154]. Corporate Governance - The company has established a transparent and independent governance structure, ensuring compliance with relevant laws and regulations, and protecting the rights of all shareholders, especially minority shareholders[159]. - The board of directors and supervisory board are operating independently, with no interference from the major shareholder, ensuring a clear separation in business, personnel, assets, and finances[160]. - The company has a robust internal audit system in place, which is responsible for evaluating internal controls and ensuring compliance with regulations[167]. - The company has established a performance evaluation and incentive mechanism for directors and senior management, ensuring transparency and fairness in the hiring and evaluation process[163]. Research and Development - The number of R&D personnel increased to 237 in 2021, up 7.24% from 221 in 2020, with R&D personnel accounting for 24.69% of the total workforce[112]. - R&D investment amounted to ¥63,863,006.18 in 2021, a decrease of 13.48% from ¥73,813,639.19 in 2020, with R&D expenditure accounting for 0.47% of operating revenue[112]. - The company aims to increase R&D investment in new products and technologies, focusing on cost reduction and product competitiveness[151]. Market Expansion - Future guidance indicates an expected revenue growth of 10-15% for the next year, driven by market expansion and new product launches[11]. - A new e-commerce platform is set to launch in Q3 2022, aimed at increasing online sales by 30%[11]. - The company’s e-commerce platform, Sumibuy, has rapidly developed into a leading vertical supply chain platform in the plastic raw materials industry, leveraging its innovative business model[75]. - Shanghai Plastmi established a new company in Jingzhou to expand its business in Central China, aiming to create a new growth point within three to five years[88]. Shareholder Engagement - The participation ratio in the 2021 first extraordinary general meeting was 26.78%[173]. - The total shares held by the board members at the end of the reporting period was 314,360,425 shares[179]. - The company has implemented a comprehensive information disclosure system to ensure timely and accurate communication with investors[164].